STAAR Surgical (Nasdaq: STAA) is expected to report Q1 earnings on May 1. Here's what Wall Street wants to see:

The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict STAAR Surgical's revenues will increase 11.3% and EPS will shrink 0.0%.

The average estimate for revenue is $17.3 million. On the bottom line, the average EPS estimate is $0.04.

Revenue details
Last quarter, STAAR Surgical booked revenue of $16.5 million. GAAP reported sales were 0.5% higher than the prior-year quarter's $16.4 million.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
Last quarter, non-GAAP EPS came in at $0.01. GAAP EPS were -$0.04 for Q4 versus $0.00 per share for the prior-year quarter.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Recent performance
For the preceding quarter, gross margin was 67.8%, 200 basis points worse than the prior-year quarter. Operating margin was -3.6%, much worse than the prior-year quarter. Net margin was -8.6%, 930 basis points worse than the prior-year quarter.

Looking ahead

The full year's average estimate for revenue is $70.6 million. The average EPS estimate is $0.16.

Investor sentiment
The stock has a two-star rating (out of five) at Motley Fool CAPS, with 77 members out of 86 rating the stock outperform, and nine members rating it underperform. Among 22 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 17 give STAAR Surgical a green thumbs-up, and five give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on STAAR Surgical is outperform, with an average price target of $9.00.

Is STAAR Surgical the best health care stock for you? Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks," including one above-average health care logistics company. Click here for instant access to this free report.